In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Pays $1.4 Billion for Igen and Gets Peace of Mind

Executive Summary

Roche's $1.4 billion acquisition of Igen left Igen shareholders gleeful and some Roche observers a bit wary of the high price tag. But by ending protracted litigation between the two companies, the deal protects one of Roche Diagnostics' core franchises, the central laboratory business.
Advertisement

Related Content

Deal Statistics Quarterly, Q3 2003
Deal Statistics Quarterly, Q3 2003
Cepheid Grapples With A Diagnostics Timetable
Cepheid Grapples With A Diagnostics Timetable
Post Abbott Consent Decree; A Changed World for Immunoassay Vendors
Post Abbott Consent Decree; A Changed World for Immunoassay Vendors
Roche Diagnostics' New Marker Mandate

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002184

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel